Action
KDR (VEGFR2)
Alt Name
LY3009806
Cyramza
Approval Jurisdiction
2014 FDA 2014 EMA
Approved for clinical use
MNSCLC colorectal cancer
CAS
947687-13-0
Commercial Vendor
Eli Lilly
Compound Image
Ramucirumab.png
Compound name
Ramucirumab
Reference
Reference 2
Approved Drug List
1